First & corresponding authorJAMDA · 2025
Evaluation of COVID-19 Diagnosis Codes for Identification of SARS-CoV-2 Infections in a Nursing Home Cohort, 2022–2023
Patel A, Payne AB, Currie DW, Franceschini T, Gensheimer A, Lutgring JD, Reddy SC, Hatfield KM. J Am Med Dir Assoc. 2025;26:105440. Published online 2024.
A retrospective cohort of 31,136 residents in 76 nursing homes across 8 states (January 2022 to June 2023). Problem-list COVID-19 codes were reconciled against SARS-CoV-2 testing and daily census records. Positive predictive value was 92% among residents continuously present in the facility, compared with 24% among those who were not, which matters for anyone using these codes to identify infections in EHR data.
DOI: 10.1016/j.jamda.2024.105440
Co-authorVaccine · 2024
Effectiveness of COVID-19 Bivalent Vaccination Against SARS-CoV-2 Infection Among Residents of US Nursing Homes, November 2022 to March 2023
Hatfield K, Wiegand R, Reddy S, Patel A, Baggs J, Franceschini T, Gensheimer A, Link-Gelles R, Jernigan J, Wallace M. Vaccine. 2024;42:126112.
Bivalent vaccine effectiveness among 6,916 residents of 76 US nursing homes, estimated with Cox proportional hazards models and time-dependent vaccination status. Adjusted effectiveness against infection was 29% compared with residents not up to date. Contributed data curation and project administration.
DOI: 10.1016/j.vaccine.2024.07.013